Skip to main content
Clinical Trials/JPRN-jRCTs051220017
JPRN-jRCTs051220017
Recruiting
Phase 2

Prospective Observational Pilot Study to Evaluate the Effect of Sevoflurane in ARDS patients

Mizobuchi Satoshi0 sites25 target enrollmentMay 1, 2022

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Mizobuchi Satoshi
Enrollment
25
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 1, 2022
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Mizobuchi Satoshi

Eligibility Criteria

Inclusion Criteria

  • 1\. patients admitted to ICU
  • 2\. patients aged 20 years or older at the time of consent
  • 3\. more than 48 hours but less than 1 week after onset of ARDS
  • 4\. patients on ventilator who are sedated with propofol
  • 5\. Patients that an average of one hour of spontaneous respiratory volume was 10 ml/kg (predicted
  • body weight\*) or more even for more than 1 hour even using a maximum dose of 3 mg/kg/h of propof
  • ol.Predicted weight: Male: 50\.0 \+ 0\.91 x (height \- 152\.4 (cm)), Female: 45\.5 \+ 0\.91 x (height \- 152\.4 (c
  • 6\. Patients who will be on a ventilator for more than 48 hours after enrollment in the study.
  • 7\. Patients who have given written explanation of this study to the patient or the substitute, and have
  • obtained written consent from the patient or the substitute.

Exclusion Criteria

  • 1\. Patients with jaundice or unexplained fever after previous use of halogenated anesthetics
  • 2\. patients with a history of hypersensitivity to anycomponent of sevoflurane
  • 3\. patients with clinical evaluation of intracranial hypertension or possible intracranial hypertension
  • 4\. patients with a history or family history of malignant hyperthermia
  • 5\. patients with muscular dystrophy, central core disease, multimini core disease, King Denborough s
  • 6\. patients with a history of epilepsy
  • 7\. patients with trauma to the trunk
  • 8\. patients with hepatic insufficiency (serum total bilirubin \> 2 mg/dL within 2 days of enrollment)
  • 9\. Patients with renal failure (serum creatinine \> 2mg/dL within 2 days of enrollment)
  • 10\. Patients with anticipated anaconda S obstruction due to excessive secretions

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Pilot prospective observational study to evaluate the safety of Thread Embedding Acupuncture
KCT0007494Sangji University Korean Medical Center100
Not yet recruiting
Not Applicable
A study to assess the status of patients undergoing surgery of oesophagus (foodpipe) using pedometer (fitness watch) and its relation with complications related to lungs occurring after surgeries and surgical outcomesHealth Condition 1: C15- Malignant neoplasm of esophagusHealth Condition 2: O- Medical and Surgical
CTRI/2024/07/071643Tata Memorial Hospital
Recruiting
Not Applicable
To study the relation between changes in blood pressure and variation in digital plethysmograph (a machine applied to a digit of the hand or foot to measure skin blood flow) measurement in a patient undergoing major surgery under complete anesthesia.Health Condition 1: null- All patients undergoing major surgery and With an arterial line and requiring some intravenous fluids
CTRI/2017/08/009224Tata Memorial Hospital
Recruiting
Not Applicable
Prospective observational study to evaluate using OCT in stent neoatherosclerosis for patients after Everolimus-eluting stent (EES) implantation in the late phase.coronary artery disease
JPRN-UMIN000033927Kobe University Graduate School of Medicine, Division of Cardiovascular Medicine200
Active, not recruiting
Not Applicable
chart review study of patients with chronic liver disease taking Ayurveda treatment to evaluate the effect on Liver functionsHealth Condition 1: K77- Liver disorders in diseases classified elsewhere
CTRI/2017/12/010913Ayurved Clinic